Words of wisdom.  Re: Is prostate-specific antigen velocity selective for clinically significant prostate cancer in screening? European randomized study of screening for prostate cancer (Rotterdam).  Wolters T, Roobol MJ, Bangma CH, Schröder PH.
Scattoni
Vincenzo
V
Department of Urology, University Vita-Salute, Scientific Institute San Raffaele, Milan, Italy. scattoni.vincenzo@hsr.it
D005060:Europe; D006801:Humans; D008297:Male; D008403:Mass Screening; D017430:Prostate-Specific Antigen / Q000097:blood*; D011471:Prostatic Neoplasms / Q000097:blood* / Q000175:diagnosis*; D016032:Randomized Controlled Trials as Topic; D013997:Time Factors
D017430:Prostate-Specific Antigen